Skip to main content

JPMORGAN CHASE & CO

Position in SYRE — Spyre Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in SYRE

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$49,395,838
+$47,333,565 QoQ
Shares Held
979,299
+1455.7% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. SYRE ranks #30 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SYRE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $49,395,838 979,299
2025-12-31 $2,062,273 62,951
2025-09-30 $4,625,490 275,984
2025-06-30 $707,765 47,279
2025-03-31 $670,504 41,556
2024-12-31 $820,572 35,248
2024-09-30 $866,800 29,473
2024-06-30 $535,368 22,772
2024-03-31 $417 11
2023-12-31 $882 41
2023-09-30 $502 41